COVID-19: Is there a role for immunonutrition in obese patient?

L Di Renzo, P Gualtieri, F Pivari, L Soldati… - Journal of translational …, 2020 - Springer
On December 12, 2019 a new coronavirus (SARS-CoV-2) emerged in Wuhan, China,
triggering a pandemic of severe acute respiratory syndrome in humans (COVID-19). Today …

Coronavirus disease 2019 and cardiometabolic disease

CW Kim, WS Aronow, WH Frishman - Cardiology in Review, 2022 - journals.lww.com
Cardiometabolic disease describes a combination of metabolic abnormalities that increases
the risk of type 2 diabetes and cardiovascular diseases, including pathological changes …

[PDF][PDF] The impact of obesity on immune response to infection and vaccine: an insight into plausible mechanisms

P Bandaru, H Rajkumar… - Endocrinol Metab Synd, 2013 - researchgate.net
Though we know much about development of obesity and its associated complications like
type II diabetes, cardiovascular diseases, hypertension and cancer, our knowledge is very …

[HTML][HTML] Global pandemics interconnected—obesity, impaired metabolic health and COVID-19

N Stefan, AL Birkenfeld, MB Schulze - Nature Reviews Endocrinology, 2021 - nature.com
Obesity and impaired metabolic health are established risk factors for the non-
communicable diseases (NCDs) type 2 diabetes mellitus, cardiovascular disease …

Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity

TB Lobato, M Gennari-Felipe, JRB Pauferro… - Frontiers in …, 2022 - frontiersin.org
Recent studies show that the metabolic characteristics of different leukocytes, such as,
lymphocytes, neutrophils, and macrophages, undergo changes both in the face of infection …

Obesity and COVID‐19: A jigsaw puzzle with still missing pieces

K Michalakis, G Panagiotou, I Ilias… - Clinical …, 2021 - Wiley Online Library
Apart from posing various mechanical and medical issues compromising general health,
obesity is a major factor for respiratory tract infections, due to specific inflammation and …

Coronavirus and obesity: could insulin resistance mediate the severity of Covid-19 infection?

FM Finucane, C Davenport - Frontiers in public health, 2020 - frontiersin.org
The rapidly evolving global epidemic of coronavirus disease 2019 (COVID-19)(1), caused
by the novel severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), presents with …

Metabolic disorders, COVID-19 and vaccine-breakthrough infections

N Stefan - Nature Reviews Endocrinology, 2022 - nature.com
Obesity and impaired metabolic health are important risk factors for severe COVID-19. Novel
data indicate that these risk factors might also promote vaccine-breakthrough SARS-CoV-2 …

SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages

GJ Martínez-Colón, K Ratnasiri, H Chen… - Science Translational …, 2022 - science.org
Obesity, characterized by chronic low-grade inflammation of the adipose tissue, is
associated with adverse coronavirus disease 2019 (COVID-19) outcomes, yet the …

Hypercoagulopathy and adipose tissue exacerbated inflammation may explain higher mortality in COVID-19 patients with obesity

G Pasquarelli-do-Nascimento… - Frontiers in …, 2020 - frontiersin.org
COVID-19, caused by SARS-CoV-2, is characterized by pneumonia, lymphopenia,
exhausted lymphocytes and a cytokine storm. Several reports from around the world have …